Table 2.
Receipt of NCCN guideline-concordant treatment among inflammatory breast cancer patients based on patient, physician, and institution characteristics, CDC POC-BP, 2004*
| Overall | Surgery | Chemotherapy | Radiation | Hormone Therapy | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | % | Number | % | Number | % | Number | % | Number | % | ||
| Total | 107 | 22 | 93 | 54 | 35 | 86 | |||||
| Patient Characteristics | |||||||||||
| Age at diagnosis | P=0.19 | ||||||||||
| <50 | 33 | 6 | 28.7 | 29 | 92.9 | 20 | 62.5 | 13 | 54.9 | 28 | 88.8 |
| 50–59 | 31 | 7 | 23.8 | 28 | 95.9 | 16 | 49.9 | 11 | 39.3 | 25 | 82.7 |
| 60–69 | 20 | 8 | 49.7 | 19 | 98.5 | 13 | 74.0 | 9 | 70.8 | 16 | 88.9 |
| ≥70 | 23 | 1 | 8.4 | 17 | 72.2 | 5 | 24.8 | 2 | 14.5 | 17 | 85.0 |
| Race | P=0.03 | ||||||||||
| White, NH | 56 | 15 | 34.2 | 51 | 94.5 | 31 | 56.0 | 23 | 54.5 | 45 | 86.0 |
| Black, NH | 40 | 6 | 15.2 | 33 | 83.0 | 19 | 54.6 | 11 | 26.3 | 33 | 84.8 |
| Hispanic | 9 | 0 | 0.0 | 8 | 94.1 | 3 | 52.7 | 0 | 0.0 | 7 | 93.8 |
| Other | 2 | 1 | 50.4 | 1 | 50.4 | 1 | 50.4 | 1 | 50.4 | 1 | 100.0 |
| Body mass index (kg/m2) | P=0.003 | ||||||||||
| 18.5–24.9 | 16 | 1 | 13.0 | 14 | 94.9 | 5 | 25.8 | 4 | 52.3 | 13 | 89.4 |
| 25–30 | 20 | 5 | 22.5 | 16 | 88.5 | 11 | 53.2 | 7 | 34.7 | 15 | 62.2 |
| >30 | 41 | 12 | 47.2 | 38 | 96.8 | 24 | 69.1 | 18 | 59.6 | 36 | 95.1 |
| Unknown | 30 | 4 | 13.6 | 25 | 86.3 | 14 | 53.1 | 6 | 30.5 | 22 | 91.0 |
| Insurance | P=0.63 | ||||||||||
| Private | 51 | 13 | 28.6 | 47 | 92.6 | 26 | 53.0 | 19 | 43.3 | 40 | 85.4 |
| Medicare | 27 | 4 | 27.2 | 22 | 93.2 | 12 | 50.5 | 7 | 56.6 | 22 | 95.8 |
| Medicaid | 22 | 3 | 16.6 | 17 | 82.3 | 10 | 53.9 | 6 | 28.9 | 18 | 69.9 |
| None/Unknown | 7 | 2 | 49.2 | 7 | 100.0 | 6 | 83.8 | 3 | 55.5 | 6 | 93.7 |
| Census-tract poverty | P=0.42 | ||||||||||
| <20% below poverty | 74 | 17 | 29.9 | 67 | 93.9 | 37 | 53.8 | 26 | 47.1 | 57 | 84.2 |
| ≥20% below poverty | 32 | 5 | 22.8 | 25 | 83.7 | 16 | 62.4 | 9 | 41.7 | 28 | 94.5 |
| Census-tract education | P=0.91 | ||||||||||
| <25% w/o HS degree | 55 | 15 | 29.3 | 51 | 94.1 | 30 | 51.8 | 23 | 47.6 | 43 | 84.7 |
| ≥25% w/o HS degree | 51 | 7 | 27.7 | 41 | 88.1 | 23 | 62.1 | 12 | 43.0 | 42 | 88.9 |
| Comorbidity index | P=0.85 | ||||||||||
| None | 38 | 9 | 33.6 | 35 | 97.6 | 20 | 56.7 | 13 | 50.1 | 32 | 86.6 |
| Mild | 43 | 8 | 23.8 | 37 | 87.4 | 24 | 58.6 | 12 | 36.5 | 32 | 86.1 |
| Moderate | 19 | 4 | 33.4 | 17 | 96.2 | 8 | 51.8 | 9 | 64.9 | 15 | 82.3 |
| Severe | 7 | 1 | 18.2 | 4 | 71.8 | 2 | 33.0 | 1 | 18.2 | 7 | 100.0 |
| Physician Characteristics | |||||||||||
| Time from graduation | |||||||||||
| Surgeon | P=0.02 | ||||||||||
| <15 years | 18 | 5 | 51.2 | 17 | 96.4 | 10 | 74.0 | 8 | 63.9 | 14 | 89.8 |
| >15 years | 39 | 10 | 31.5 | 39 | 100.0 | 24 | 62.0 | 15 | 52.2 | 33 | 91.4 |
| Unknown | 39 | 7 | 16.8 | 37 | 97.7 | 20 | 47.4 | 12 | 38.8 | 31 | 76.5 |
| Radiation oncologist | P=0.37 | ||||||||||
| <15 years | 16 | 8 | 60.1 | 16 | 100.0 | 11 | 72.2 | 12 | 86.0 | 15 | 100.0 |
| >15 years | 32 | 10 | 38.1 | 30 | 96.4 | 23 | 74.6 | 16 | 56.8 | 28 | 89.7 |
| Unknown | 17 | 4 | 33.0 | 17 | 100.0 | 11 | 65.7 | 7 | 64.0 | 15 | 94.0 |
| Chemotherapy oncologist | P=0.72 | ||||||||||
| <15 years | 15 | 3 | 31.3 | 11 | 83.1 | 8 | 73.9 | 4 | 36.5 | 15 | 100.0 |
| >15 years | 58 | 15 | 36.4 | 53 | 95.8 | 35 | 64.6 | 23 | 53.8 | 46 | 87.8 |
| Unknown | 19 | 4 | 24.8 | 19 | 100.0 | 11 | 56.6 | 7 | 54.7 | 16 | 89.7 |
| Hospital Characteristics | |||||||||||
| CoC Accredited | P=0.50 | ||||||||||
| Yes | 57 | 14 | 32.6 | 51 | 91.4 | 33 | 57.6 | 22 | 49.2 | 46 | 89.8 |
| No | 38 | 6 | 22.8 | 33 | 93.0 | 16 | 54.0 | 9 | 36.7 | 31 | 79.1 |
| Teaching status | P=0.62 | ||||||||||
| Teaching | 48 | 9 | 31.7 | 43 | 94.9 | 30 | 65.5 | 14 | 39.3 | 36 | 81.1 |
| Non-teaching | 45 | 10 | 24.3 | 40 | 89.7 | 18 | 43.0 | 16 | 51.3 | 38 | 91.2 |
| Size (number of beds) | P=0.02 | ||||||||||
| <200 | 24 | 2 | 6.0 | 18 | 70.7 | 5 | 13.2 | 5 | 27.9 | 18 | 85.0 |
| 200–299 | 12 | 4 | 44.5 | 12 | 100.0 | 7 | 75.0 | 5 | 62.0 | 10 | 84.2 |
| 300–399 | 15 | 2 | 8.0 | 15 | 100.0 | 8 | 39.7 | 5 | 49.9 | 11 | 79.5 |
| ≥400 | 42 | 11 | 38.2 | 38 | 95.2 | 28 | 70.3 | 15 | 43.1 | 35 | 88.2 |
Abbreviations: CoC, Commission on Cancer; NH, non-Hispanic; NPCR POC-BP, National Program of Cancer Registries Breast and Prostate Cancer Data Quality and Patterns of Care Study.
*
Percentages weighted to reflect the sampling design. Chemotherapy oncologist refers to the physician that determined the chemotherapy regimen; it was not a medical oncologist in all cases. Time from graduation refers to graduation from medical school. Calculation of chi-square test p-values excluded categories of unknown status. For race, p-value compares non-Hispanic White to all others.